Drug And Gene Delivery Devices Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034
Discover trends, market shifts, and competitive outlooks for the drug and gene delivery devices industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Are the Key Milestones in the Drug And Gene Delivery Devices Market’s Growth Trajectory From 2025 To 2034?
In recent times, the market size for drug and gene delivery devices has seen robust growth. The market is projected to expand from $0.61 billion in 2024 to $0.67 billion in 2025, with a compound annual growth rate (CAGR) of 9.0%. The past growth can be credited to factors like the advancement of healthcare infrastructure, scaling up of personalized gene therapy programs, growing emphasis on preventive healthcare, treatment of rare and orphan diseases, and rising public consciousness regarding health and available treatments.
The market for drug and gene delivery devices is predicted to witness a robust growth in the coming years, escalating to $0.93 billion by 2029 with a compound annual growth rate (CAGR) of 8.7%. Factors contributing to this expected growth in the forecast period are the rising prevalence of chronic illnesses, increasing demand for tailored medicines, growing awareness and acceptance of gene therapies, demand for non-invasive and minimally invasive procedures, and widespread preference for direct-to-patient delivery models. Further, trends projected to drive this growth in the forecast period encompass progress in biotechnology and genetic engineering, advancements in drug delivery technology, increased investment in research and development, establishment of innovative delivery platforms, and strides made in diagnostic technologies.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19404&type=smp
What External and Internal Drivers Are Contributing to the Growth of the Drug And Gene Delivery Devices Market?
The accelerating use of gene therapy is projected to fuel the expansion of the drug and gene delivery devices market in the future. Gene therapy, which involves modifying or manipulating genetic material within a patient’s cells to treat or prevent illnesses, is becoming more popular due to its ability to address genetic disorders and chronic diseases at their origin, offering revolutionary treatment alternatives when traditional methods fail. Drug and gene delivery devices play a critical role in gene therapy, enabling the accurate targeting and controlled release of therapeutic genes, which increases the effectiveness of the treatment. For example, the National Centre for Biotechnology Information, a leading US scientific research resource, reported in November 2023 that the projected number of new patients receiving gene therapies will increase from 16,244 in 2020 to 94,696 in 2025. Thus, the escalating use of gene therapy is bolstering the development of the drug and gene delivery devices market.
What Segment Types Define the Drug And Gene Delivery Devices Market Structure?
The drug and gene delivery devicesmarket covered in this report is segmented –
1) By Vector: Viral, Non-viral
2) By Method: In Situ, Ex Vivo
3) By Route Of Administration: Oral, Inhalation, Transdermal, Injectable, Ocular, Nasal, Topical
Subsegments:
1) By Viral: Adenovirus Vectors, Lentivirus Vectors, Adeno-Associated Virus (AAV) Vectors, Herpes Simplex Virus (HSV) Vectors, Retrovirus Vectors, Baculovirus Vectors, Vaccinia Virus Vectors, Sendai Virus Vectors
2) By Non-Viral: Lipid Nanoparticles (LNP), Polymeric Nanoparticles, Liposomes, Dendrimers, Naked DNA/RNA Delivery, Electroporation-Based Delivery Systems, Nanoparticle-Based Delivery Systems, Polymer Micelles And Hydrogels.
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=19404&type=smp
Which Geographic Areas Hold the Strongest Growth Potential in the Drug And Gene Delivery Devices Market?
North America was the largest region in the drug and gene delivery devices market in 2024. The regions covered in the drug and gene delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Market Trends and Innovations Are Shaping the Future of the Drug And Gene Delivery Devices Industry?
Leading firms in the drug and gene delivery devices market are concentrating their efforts on creating superior products, such as artificial intelligence (AI) devices, to gain a competitive upper hand. AI technology’s role in drug delivery involves using AI methods and algorithms to enhance the accuracy, efficiency, and effectiveness of drug delivery systems. For example, in December 2023, Envoya Inc., a company in the U.S. known for developing polymer-based nanoparticles for targeted delivery, introduced a groundbreaking gene therapy drug delivery platform. This platform amalgamates biopolymer-nanoparticles and AI to overcome significant drawbacks in the current gene therapy technologies, such as viral vectors and lipid nanoparticles. It is designed to transcend the constraints of present gene therapy delivery systems that have been hindered by safety issues, limited payload capacities, and restricted tissue targeting.
View the full report here:
What Is the Definition of the Drug And Gene Delivery Devices Market?
Drug and gene delivery devices are tools designed to transport pharmaceuticals or genetic material into the body for therapeutic purposes, enabling targeted treatment of diseases at the molecular level with enhanced precision and efficacy. These devices are crucial in advancing personalized medicine by ensuring controlled release and optimal delivery of therapeutic agents to specific cells or tissues, minimizing side effects, and maximizing treatment effectiveness.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19404
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
